Pharmasofttech Awacs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 17 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 15.09%
(FY 2022)
- Profit 20.24%
(FY 2022)
- Ebitda 14.40%
(FY 2022)
- Net Worth 15.81%
(FY 2022)
- Total Assets -0.72%
(FY 2022)
About Pharmasofttech Awacs
- CIN/LLPIN
U74900MH2007PTC174358
- Company No.
174358
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Sep 2007
- Date of AGM
07 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pharmasofttech Awacs?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakeshchandra Sinha  | Director | 26-Aug-2021 | Current |
| Mukund Thakkar | Director | 26-Aug-2021 | Current |
| Harish Hulyalkar | Director | 26-Aug-2021 | Current |
| Alok Joshi | Director | 24-Aug-2022 | Current |
Kalyanasundaram Subramanian  | Director | 30-Mar-2021 | Current |
| Sanjay Dube | Additional Director | 16-Nov-2022 | Current |
Financial Performance and Corporate Structure Insights of Pharmasofttech Awacs.
Pharmasofttech Awacs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15.09% increase. The company also saw a substantial improvement in profitability, with a 20.24% increase in profit. The company's net worth Soared by an impressive increase of 15.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmasofttech Awacs?
Unlock access to Pharmasofttech Awacs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sun Pharma Laboratories LimitedActive 27 years 11 monthsKalyanasundaram Subramanian and Rakeshchandra Sinha are mutual person
Sun Pharma Distributors LimitedActive 5 years 9 monthsKalyanasundaram Subramanian and Rakeshchandra Sinha are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmasofttech Awacs?
Pharmasofttech Awacs has a workforce of 96 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmasofttech Awacs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmasofttech Awacs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
